These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2450170)
1. Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. Cattaneo A; Rapposelli B; Calissano P J Neurochem; 1988 Apr; 50(4):1003-10. PubMed ID: 2450170 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against beta nerve growth factor and their effects on receptor binding and biological activity. Zimmermann A; Sutter A; Shooter EM Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4611-5. PubMed ID: 6270686 [TBL] [Abstract][Full Text] [Related]
3. Two distinct monoclonal antibodies raised against mouse beta nerve growth factor. Generation of bi-specific anti-nerve growth factor anti-horseradish peroxidase antibodies for use in a homogeneous enzyme immunoassay. Kenigsberg RL; Elliott PJ; Cuello AC J Immunol Methods; 1991 Feb; 136(2):247-57. PubMed ID: 1999653 [TBL] [Abstract][Full Text] [Related]
6. Characterization of ultra-high affinity monoclonal antibodies with a dimeric, symmetrical antigen: inhibition of the receptor recognition site of nerve growth factor. Vroegop SM; Crumm E; Buxser SE Mol Immunol; 1992 Mar; 29(3):411-23. PubMed ID: 1313539 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to the cell surface and a soluble form of the human nerve growth factor receptor. Clagett-Dame M; Chung C; Chao MV; DiStefano PS J Neurosci Res; 1990 Dec; 27(4):642-50. PubMed ID: 1706784 [TBL] [Abstract][Full Text] [Related]
8. Rat NGF receptor is recognized by the tumor-associated antigen monoclonal antibody 217c. Ferrari G; Fabris M; Polato P; Skaper SD; Fiori MG; Yan Q Exp Neurol; 1991 May; 112(2):183-94. PubMed ID: 1709875 [TBL] [Abstract][Full Text] [Related]
9. Biochemical, immunocytochemical and morphological evidence for an interaction between thyroid hormone and nerve growth factor in the developing cerebellum of normal and hypothyroid rats. Legrand C; Clos J Dev Neurosci; 1991; 13(6):382-96. PubMed ID: 1667097 [TBL] [Abstract][Full Text] [Related]
10. Molecular investigations on the high-affinity nerve growth factor receptor. Meakin SO; Shooter EM Neuron; 1991 Jan; 6(1):153-63. PubMed ID: 1702649 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen. Thanavala YM; Bond A; Tedder R; Hay FC; Roitt IM Immunology; 1985 Jun; 55(2):197-204. PubMed ID: 2408999 [TBL] [Abstract][Full Text] [Related]
12. Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor. DiStefano PS; Schweitzer JB; Taniuchi M; Johnson EM J Cell Biol; 1985 Sep; 101(3):1107-14. PubMed ID: 2993314 [TBL] [Abstract][Full Text] [Related]
13. Probing the structure-function relationship of nerve growth factor. Vroegop S; Decker D; Hinzmann J; Poorman R; Buxser S J Protein Chem; 1992 Feb; 11(1):71-82. PubMed ID: 1325153 [TBL] [Abstract][Full Text] [Related]
14. Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors. Weskamp G; Reichardt LF Neuron; 1991 Apr; 6(4):649-63. PubMed ID: 1849725 [TBL] [Abstract][Full Text] [Related]
15. Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. Kumar S; Huber J; Peña LA; Perez-Polo JR; Werrbach-Perez K; de Vellis J J Neurosci Res; 1990 Nov; 27(3):408-17. PubMed ID: 1965839 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor. Taniuchi M; Johnson EM J Cell Biol; 1985 Sep; 101(3):1100-6. PubMed ID: 2411735 [TBL] [Abstract][Full Text] [Related]
17. Production of a monoclonal antibody directed against the nerve growth factor receptor from sympathetic membranes. Morgan CJ; Bradshaw RA J Cell Biochem; 1985; 27(2):121-32. PubMed ID: 2985634 [TBL] [Abstract][Full Text] [Related]
18. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies. White J; Haskins KM; Marrack P; Kappler J J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of beta-nerve growth factor receptors in the forebrain of the rat. Dawbarn D; Allen SJ; Semenenko FM Brain Res; 1988 Feb; 440(1):185-9. PubMed ID: 2833990 [TBL] [Abstract][Full Text] [Related]
20. Human x human hybridomas from patients with myasthenia gravis: possible tools for idiotypic therapy for myasthenia. Blair DA; Mihovilovic M; Agius MA; Fairclough RH; Richman DP Ann N Y Acad Sci; 1987; 505():155-67. PubMed ID: 3500665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]